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ABSTRACT
Binding-induced conformational changes of a pro-
tein at regions distant from the binding site may play
crucial roles in protein function and regulation. The
p53 tumour suppressor is an example of such an
allosterically regulated protein. Little is known, how-
ever, about how DNA binding can affect distal sites
for transcription factors. Furthermore, the molecu-
lar details of how a local perturbation is transmitted
through a protein structure are generally elusive and
occur on timescales hard to explore by simulations.
Thus, we employed state-of-the-art enhanced sam-
pling atomistic simulations to unveil DNA-induced
effects on p53 structure and dynamics that modu-
late the recruitment of cofactors and the impact of
phosphorylation at Ser215. We show that DNA inter-
action promotes a conformational change in a region
3 nm away from the DNA binding site. Specifically,
binding to DNA increases the population of an oc-
cluded minor state at this distal site by more than
4-fold, whereas phosphorylation traps the protein in
its major state. In the minor conformation, the in-
terface of p53 that binds biological partners related
to p53 transcription-independent functions is not ac-
cessible. Significantly, our study reveals a mecha-
nism of DNA-mediated protection of p53 from interac-
tions with partners involved in the p53 transcription-
independent signalling. This also suggests that con-
formational dynamics is tightly related to p53 sig-
nalling.
INTRODUCTION
Allosteric mechanisms involve the transmission of local
structural perturbations, such as those incurred by interac-
tionswith ligands, to distal protein regions (1–5). It has been
proposed that allostery is an intrinsic feature of proteins
(6,7) and is best understood in terms of a shift in the dis-
tribution of pre-existing states that are present in both the
free and bound protein (8). The effects induced at distant
sites can involve major conformational changes (9) or more
subtle localized changes in either dynamics or conforma-
tion (10). The transmission of structural effects across long
distances relies on the dynamic coupling between different
residues (3,11–14). In this view, the network of residue con-
tacts and the intrinsic dynamics of the protein are crucial
components of long-range communication and protein reg-
ulation.
Given the key role that both conformational changes and
long-range effects play in the regulation of cellular events
(15–17), understanding these events in atomistic detail is an
important goal (18,19). Atomic-level molecular dynamics
(MD) simulations have previously been employed to elu-
cidate the molecular mechanisms that underlie structural
communication over long distances (20). MD can provide
information on protein dynamics spanning time-scales from
femto- to milli-seconds (21) and long-range communica-
tion paths can be inferred from MD ensembles (20,22).
Enhanced sampling techniques, such as parallel-tempering
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metadynamics (PT-metaD) (23), can be used to determine
the free energy landscape associated with conformational
transitions (24–28).We have recently shown that PT-metaD,
when combined with the most accurate protein force fields
makes it possible to map the free energy associated with
conformational changes with accuracy and precision (28).
Hub proteins, such as the p53 tumour suppressor, regu-
late fundamental cellular processes through protein–protein
interactions and allosteric mechanisms. p53 interacts with
multiple partners and integrates diverse signalling pathways
to initiate distinct cellular responses (29–31). The ability to
exploit the same region for interactions with different bio-
logical partners is crucial in hub proteins and is often asso-
ciated with allosteric modulation (32–34). Although many
experimental and computational studies have addressed im-
portant aspects of p53-mediated interactions (29,30,35,36),
a detailed molecular understanding of the mechanisms un-
derlying long-range structural communication is far from
complete. Only a limited number of structures of the com-
plexes between p53 and its biological partners have been de-
termined, limiting the knowledge on the effects of protein–
protein interactions on p53 structure and function. Further-
more, since allosteric signalling often involves shifts in the
populations of dynamically interconverting conformations
that are present in both the unbound and bound states, it is
challenging to understand regulation based purely on static
protein structures.
The DNA-binding domain (DBD) of p53 is especially
important for both cytosolic and nuclear functions of the
protein (29,37,38). Even though the p53 DBD does not ap-
pear to undergo a large conformational change upon bind-
ing with cofactors, a slow conformational exchange process
in the proximity of the disordered N-terminal region has
been identified by NMR experiments on the free protein
(39). Previous studies focused mostly on local changes that
occur at the DNA-binding interface and L1 loop (40–44),
and much less is known about conformational changes at
more distal sites (45).
To gain a deeper insight into conformational rearrange-
ments that underlie p53 regulation and function, we have
used all-atom explicit-solvent MD simulations, including
PT-metaD enhanced sampling methods (23), to study p53
DBD (Figure 1A) in its DNA-bound (p53DBD-DNA) and un-
bound (p53DBD) forms. We identified a coupling between
conformational changes at the interface for DNA-binding
and changes in a loop (S6-S7 loop, residues 207–213, Fig-
ure 1B), which is located more than 3 nm away from the
DNA-binding and whose conformational ensemble is mod-
ulated by DNA. In particular, we found that conforma-
tional changes in the L1 loop at the DNA-binding inter-
face are coupled to changes in S6-S7 loop, which in turn
is in proximity to the N-terminal disordered tail, for which
a slow exchange was observed by NMR (39). We also ob-
served that Aurora kinases-mediated phosphorylation at
Ser215 (46–48) modulates the conformational properties of
the S6-S7 loop, providing an additional layer of p53 regu-
lation. The coupling between the L1 and S6-S7 loops pro-
vides a mechanism for DNA binding to exert long-range
effects, thus linking our findings to p53 function. Themech-
anisms here illustrated highlight one more time the impor-
tant role of loops in regulation of protein function (5). In
Figure 1. (A) Structural features of the p53 DBD. The 3D structure of p53
DBD in complex with DNA (PDB entry 1TSR) is shown as a cartoon of
different shades of colours from the N- (yellow) to the C-terminus (green).
(B) Substates of the S6-S7 loop in the 2D subspace described by the first
and second PCs. The different substates are indicated by capital letters (A-
D). The average 3D structure identified for each substate is represented as
a cartoon and the conformations of the S6-S7 loop are highlighted in red,
orange, yellow, green and cyan for A, B, C and D, respectively.
particular, by comparing simulations in the presence and
absence of DNA, we observed a population shift upon
DNAbinding toward p53DBD conformations that disfavour
the interaction with partners involved in p53 transcription-
independent apoptotic functions, such as Ku70.
MATERIALS AND METHODS
Preparation of molecular dynamics (MD) simulations
We used the X-ray structure of the p53 DBD (PDB en-
try 1TSR chain B, residues 95–289, in complex with DNA
(PDB entry 1TSR chains E and F) as the initial struc-
ture for classical MD p53DBD-DNA simulations (49). We em-
ployed the same structure (after removing the DNA) as
starting structure for classical MD p53DBD simulations. We
also performed additional simulations (p53DBD-DNA(91-289)
and p53DBD(91-289)) using both MD and PT-metaD starting
from the X-ray structure of the p53 DBD (50) with four
additional residues at the N-terminus (PDB entry 2XWR
chain A, residues 91–289). The atomic coordinates of the
DNA were modelled from 1TSR upon structural align-
ment of the two p53 DBDs. Further details are provided in
Supplementary Text S1. MD simulations were performed
with Gromacs 4.5 (51) coupled to the PLUMED 1.3 plu-
gin for PT-metaD (52). The systems were solvated in a
dodecahedral box of Tip3p water molecules (53) at 150
mM NaCl, applying periodic boundary conditions with
a minimum distance of 1.3 nm between protein and box
edges. We used the CHARMM22/CMAP protein force
field (54) and CHARMM27 parameters for DNA (55).
In both systems the interactions between zinc (Zn2+) and
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its coordinating residues were treated using a non-bonded
model with van der Waals and electrostatic terms avail-
able in the CHARMM22/CMAP force field. To further
confirm our results, we also performed PT-metaD simula-
tions using Zn2+ parameters developed by Merz et al. (56)
combined with the CHARMM22/CMAP force field for
p53DBD-DNA(91–289), as well as simulations with the protein
CHARMM22* force field (57) for p53DBD-DNA(91–289) and
p53DBD(91–289).
Classical MD simulations
We collected a total of 25 independent classical MD simu-
lations (replicates) of 50–100 ns each (Supplementary Fig-
ure S1) at 300 K and 1 atm using the isothermal-isobaric
ensemble (NPT) and an external Berendsen bath with ther-
mal and pressure coupling of 0.1 and 1 ps, respectively. The
list of non-bonded interactions was updated every 10 steps
and conformations stored every 4 ps. Other details on the
preparatory steps and the parameters used forMD and PT-
metaD are provided in Supplementary Text S1.
Analyses of MD trajectories with TimeScapes
We used the TimeScapes package version 1.3 (58) to iden-
tify conformational changes associated with DNA interac-
tions with the p53 DBD during the MD simulations. The
TimeScapes algorithm identifies conformational changes
through analysis of the formation and breaking of atomic
contacts in the system under investigation. In particular,
we employed two different metrics available in Timescapes,
i.e. (i) a coarse-grained model to calculate contacts be-
tween residue side chains and to measure system activity
that is defined as the total number of changes in contact
per unit time and (ii) a finite difference approximation of
the first derivative of the total Generalized Masked Delau-
nay (GMD) tetrahedralization-based activity to define lo-
cal minima (basins) and local maxima (transitions) (58).We
used the same residue subset used for the principal compo-
nent analysis (PCA) (see Supplementary Text S1), consid-
ering all protein atoms. The half width median filter was
set to 2 ns. To separate contacts/non-contacts between the
side chains of each pair of residues we set a buffer region
with edge order of 2 (contacts) and 3 (buffer) for the GMD
graphs, as suggested in the original publication (58) to avoid
re-crossing events in the MD simulations.
Enhanced sampling MD simulations
We used PT-metaD (23) in the well-tempered ensemble
(59) to enhance sampling. In these simulations, sampling
of the free energy surface is enhanced by adding a history-
dependent potential to a set of collective variables (CVs).
We also further enhanced the sampling by allowing ex-
changes between different temperatures through a replica
exchange approach. We employed eight replicas (at 296K,
298K, 300K, 308K, 320K, 332K, 345K, 358K) where the
width of the energy distribution (of all but the ‘neutral’
298K replica) was increased as previously described (24).
All replicas are further subject to an additional biasing force
through metaD simulations in which a Gaussian of width
0.1 nm in all the four dimensions is deposited in the collec-
tive variable space every 4 ps (initial height of 0.12 kcal/mol
and bias factor of 6). The set of CVs are C–C distances
that are described in Supplementary Text S1 and Supple-
mentary Figure S2. PT-metaD simulations were carried out
for 0.3 s per replica (aggregate time 2.4 s). Convergence
of the simulations is discussed in Supplementary Figure
S2B.
Paths of communication
The shortest paths of communication between Lys120
and residues of S6-S7 loop were calculated from the
unbiased MD simulations using the Protein Structure
Network/Linear Mutual Information (PSN/LMI) method
(60). Briefly, the C LMI matrix was calculated by averag-
ing over non-overlapping windows of 1 ns, and using a cut-
off of 0.4 to reduce noise. The Icrit value employed in our
simulations was 7, calculated as previously described (61).
The PSN was calculated for each structure and only edges
present in at least half of the simulation frames were consid-
ered. The PSN, LMI and PSN-LMI calculations were per-
formed usingWORDOM (62).Wemapped the paths on the
3D structures by the xPyder (63) plugin for PyMOL.
Protein Interactions by Structural Matching (PRISM)
PRISM is a motif-based software to predict protein-protein
interactions (64). It includes a rigid-body structural com-
parison of target proteins to known templates of protein–
protein interfaces and a flexible refinement using a docking
energy function. We employed PRISM (64,65) to screen 54
different potential interaction partners for the p53 DBD.
We used 40 conformations of p53 DBD from our simula-
tions, including both the DNA-bound and -unbound states,
along with the average structures from each PCA substate
and they were subjected to energy minimization with the
steepest descent algorithm. The potential interaction part-
ners selected in the first round step were then re-submitted
to PRISM2.0 and evaluated on the basis of their dock-
ing energy scores considering an energy value cutoff of
−2.39 kcal/mol for favourable interactions, as previously
suggested by the developers of the method (64). To bench-
mark our PRISM analyses, we performed calculations us-
ing four crystallographic structures of p53DBDobtained in
presence or absence of DNA and known p53 partners for
which experimental data of the complexes with p53 DBD
are already available (see Supplementary Text S1 for details
on the selected structures). We also calculated the Inter-
face Similarity score (IS-score), which is often used to as-
sess models of protein-protein complexes (66,67). IS-score
was calculated for those models for which a reference exper-
imental structure of the complex was available. This score
evaluates geometric and side-chain contact similarity of the
predicted interface with respect to a reference complex in-
terface and it varies in a range from 0 to 1 for divergent and
perfect models, respectively.
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RESULTS AND DISCUSSION
Prediction of long-range coupling between the DNA-binding
L1 loop and the S6-S7 loop
To identify the regions of p53DBD that are influenced by the
interaction with DNA, we first performed unbiased MD
simulations and a joint PCA of p53DBD and p53DBD-DNA,
inspired by a previously published work (43). Comparing
the subspace described by the two first principal compo-
nents (Supplementary Figure S3), we observe (as expected)
noticeable differences in the dynamics of the L1 loop that is
in direct contact with DNA (Supplementary Figure S3). In
the simulations, in the absence of DNA, we find that the L1
loop also samples conformations known as ‘recessed states’
(Supplementary Figure S4, Figure 2A and B). These states
are involved in the early events of DNA recognition (43)
as experimental studies have shown that the L1 loop pop-
ulates two different conformations, one extended and elon-
gated toward the DNA and one ‘recessed’ (Supplementary
Figure S4) (42).
More intriguingly, we also observed differences in the
dynamics of the S6-S7 loop when comparing simulations
of p53DBD and p53DBD-DNA (Supplementary Figure S3A).
This loop connects the S6 and S7 -strands (Supplemen-
tary Figure S3A) and is located 3 nm away from the DNA-
binding site.We identified four distinct conformational sub-
states for this loop in the PCA subspace, labelledA-D (Sup-
plementary Figure S3B, Figure 2A). The starting structure
for the simulations has the S6-S7 loop in an A-like confor-
mation and L1 in an extended conformation. Simulations
of the DNA-bound protein suggest that interaction with
DNApromotesB- andC-like structures (occluded states for
the S6-S7 loop), in which the S6-S7 loop gets closer to the
flanking S4 -strand (Supplementary Figure S4B). Similar
observations on structural heterogeneity of the S6-S7 loop
were also pointed out in a recent simulation study of a p53
mutant variant (45).
To further examine the potential coupling between con-
formational changes at the DNA-binding interface and
those in the S6-S7 loop, we selected a set of key residues
for DNA interaction (Lys120 in L1, Arg248 in L3, Arg273
in loop S10-H2 and Arg280 in H2 -helix) and analysed
their conformations in the different PCA regions (Sup-
plementary Figure S5). Lys120, Cys277 and Arg280 are
residues known to be important for the interaction with
the DNA major groove, whereas Arg248, Ala276, Arg273
and Ser241 mostly mediate the interaction with the mi-
nor groove. Among those, we focused on Lys120, Arg248,
Arg273 and Arg280 since their substitutions are associated
with severe abrogation of p53 DNA binding (68,69). More-
over, Arg248 and Arg273 are also altered in many human
tumours (68,69).
Although our definition of the four substates A–D was
solely based on the conformation of the S6-S7 loop, we ob-
served that the different conformations of the S6-S7 loop
also correlate with distinct conformational preferences in
L1, which ranges from substates not optimal for DNA in-
teraction (in A and D conformations) and DNA-bound-
like substates (in C conformations) (Figure 2A and B). In
p53DBD B-like states, we observed both Lys120 conforma-
tions. In particular, in D and A, the side chain of Lys120 is
displaced outward by 1 nm compared with the states sam-
pled in p53DBD-DNA simulations (Figure 2A, Supplementary
Figure S5). These structures also resemble experimentally
observed ‘recessed states’ (42) (Figure 2B, Supplementary
Figure S4B).Recently, Verma et al. also showed byMDsim-
ulations of the p53DBD that the L1 loop populates recessed
and extended conformations in the absence of theDNAand
that these states are likely to be associated with motions in
the S6-S7 loop (43). In our simulations, Lys120 is charac-
terized by conformations optimal for DNA interaction in
structures from state C (Figure 2A, Supplementary Figure
S5). In contrast, arginine residues at 248, 273 and 280 posi-
tions are less perturbed by DNA interaction and decoupled
from the S6-S7 conformations (Figure 2A, Supplementary
Figure S5), in agreement with previous simulations (40).
For an additional characterization of the structural tran-
sitions occurring in p53 simulations, especially considering
the limitations associated to PCA analyses of conventional
MD simulations (5,58,70–72), we also employed a method
based on the so-called ‘higher-order statistics’ using the
TimeScapes software (58). This analysis is based on mon-
itoring the time-dependent formation and breaking of side-
chain contacts in MD trajectories to pinpoint conforma-
tional rearrangements. We performed the analysis on each
of the p53DBD and p53DBD-DNA simulations, measuring the
GMD-based ‘system activity’ considered as the total num-
ber of contact changes over the unit of time. From this anal-
ysis, we identified basins of minimal activity (GMD min-
ima) of the trajectory, corresponding to stable states of the
protein. We then analysed in details the structures of each
minima identified by GMD analyses with attention to the
conformations of the S6-S7 and L1 loops (Figure 2C–L and
Supplementary Figure S6). We calculated the C RMSD
of the S6-S7 loop between structures of each GMD mini-
mum and the average conformations of the different sub-
states identified by the PCA analysis (A, B, C, D). More-
over, we calculated the C RMSD of the L1 loop among
the structures in eachGMDminimum and themonomersB
and C of the X-ray structure (42) of the p53 tetramer (PDB
ID 3Q06) that we can use as references of both the extended
and the recessed states of the L1 loop. We then classified
each GMD minimum according to its RMSD to the afore-
mentioned L1 loop conformations.
The TimeScapes analysis confirmed that the S6-S7 loop
and the L1 loop have different conformational propen-
sities in p53DBD and simulations (Figure 2C–H and I–L
for p53DBD-DNA and for p53DBD simulations, respectively).
Indeed, the GMD graph of p53DBD simulations showed
that the events of high activity are associated with rear-
rangements in the L1 loop, promoting the loss of extended
states in favour of recessed-like states (Figure 2I–L), along
with changes in the L3, L2 and S7-S8 loops. Further-
more, in GMD minima of p53DBD simulations, the loop
S6-S7 did not undergo large rearrangements and did not
significantly populate C-like conformations. On the con-
trary, high-activity events were not generally associated to
changes in the L1 loop in the p53DBD-DNA simulations (Fig-
ure 2C–H). They are, however, often associatedwith confor-
mational changes in the loop S6-S7 (Figure 2C–H), and C-
like DNA-bound conformations could be observed. More-
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Figure 2. (A) Average structure of each conformational substate of the principal component analysis (PCA) subspace. The average conformations from
A-D are shown as red, orange, yellow and green cartoons, respectively. The DNA-interacting residues (Lys120, Arg248, Arg273, Arg280) are shown as
sticks. We here show the coupling between the different structural states of S6-S7 loop and conformations of L1 loop ranging from states not competent
for DNA interaction as A (red) andD (green) and DNA-bound-like states as B (orange) and C (yellow). The DNA is taken from the initial structure (PDB
entry 1TSR, chain B) and shown as a reference in grey. (B) Conformations of loop L1 in extended (pink) or recessed (blue) state in the X-ray structure
of p53 tetramer (PDB entry 3Q06 monomer B and C). The L1 loop and the S6-S7 loop of a conformation from a generalized masked delaunay (GMD)
minimum are shown as red cartoons for reference. (C–L) Activity level during p53DBD-DNA (C–H) and p53DBD (I–L) simulations.We used an approach that
employs a contact metric based on higher-order statistics (GMD) to describe conformational changes in the p53 DBD, measured as activity (see Materials
andMethods). The GMD activity plot is reported for each simulation. We identified basins of minimal activity (GMDminima) of the trajectories, and the
corresponding structures are reported as cartoons in Supplementary Figure S6. We showed the conformations of the S6-S7 and L1 loops in each GMD
minimum compared to the states observed by (A) PCA and the recessed and extended states observed in X-ray structure of (B) p53 tetramer (PDB entry
3Q06), respectively. Structural states of the S6-S7 loop in GMD minima are represented by spheres coloured according to the structural similarity with
average conformations of substates identified by PCA (A) (A red, B orange, C yellow, D green) measured by CRMSD of the S6-S7 loop. Structural states
of the L1 loop in GMD minima are represented by rectangular boxes coloured according to their structural similarity with extended (pink) or recessed
(blue) state in the X-ray structure of p53 tetramer (B) (PDB entry 3Q06, monomers B and C, respectively) measured by C RMSD of L1 loop.
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over, each GMDminimum characterized by the S6-S7 loop
in aC-likeDNA-bound conformations featured theL1 loop
always in extended conformations (Figure 2E and H). On
the contrary, A, B and D-like conformations of the S6-S7
loop were associated both with extended and recessed con-
formations of the L1 loop (Figure 2I–L). These results fur-
ther suggest the long-range coupling between conforma-
tions of the L1DNA-binding loop and the S6-S7 distal loop
that was observed by PCAanalyses (Figure 2A, Supplemen-
tary Figure S3B).
Both X-ray crystal structures (50) and NMR relaxation
dispersion experiments (39) of a longer p53DBD(91–289) vari-
ant are suggestive of a role of the N-terminal tail in modu-
lating the conformational ensemble of the p53DBD (Figure
3A). Thus, we performed an additional set of p53DBD(91–289)
classical MD simulations to examine whether the inclu-
sion of the N-terminal residues influences the dynamics of
the S6-S7 loop. In agreement with previous experimental
data (39,50,73), our simulations show that the N-terminal
residues can interact with the p53 DBD through a network
of hydrogen bonds, including residues in the proximity of
the S6-S7 loop (such as Thr211 and Arg213) (Figure 3A).
However, we do not expect classical unbiased MD simu-
lations lasting a few hundreds of ns to sample the longer
timescale dynamics revealed by the NMR experiments (39),
as we also previously observed for another protein (28). In-
deed, our classical MD simulations of p53DBD(91–289) do not
show substantial differences between the DNA-bound and
-unbound forms of the S6-S7 loop (Supplementary Figure
S7). This result suggests that theN-terminal residuesmodu-
late the dynamics of the S6-S7 loop since in its absence MD
simulations of the p53DBD were characterized by a larger
amplitude motions of the loop on the ns-timescale. The in-
troduction of theN-terminal residues in the study of the p53
DBD dynamical properties is thus crucially important for
modelling and simulation purposes and it is here explored
for the first time.
Since p53 exists in solution as a tetramer (39,74) it is im-
portant to verify that the conformations of the S6-S7 loop
observed in our study are still relevant in the oligomeric as-
sembly. Thus, we compared the structures sampled by our
simulations with the known experimental quaternary struc-
tures of p53 (SupplementaryFigure S8). The different S6-S7
conformations nicely fit in the tetrameric assembly without
structural clashes. The loop residues, apart from Phe212,
are generally solvent exposed and available for interaction
with biological partners.
Lastly, we employed methods inspired by graph theory
to analyse our MD simulations and to provide residue-level
insight into the long-range coupling between the L1 DNA-
binding loop and the S6-S7 loop. Even in the unbound pro-
tein, we found evidence of structural communication be-
tween the L1 and the S6-S7 loops in both A-like and C-like
structures (Figure 3B and C, Supplementary Table S1). The
interaction with DNA strengthened the coupling between
the two regions and also promoted new communication
paths that were not observed in the free protein. In more de-
tail, the communication between the two loops propagated
from the DNA-binding site across the external face of the
core -sheet and through the L3 loop and the N-terminal
tail in the p53DBD-DNA ensemble.
DNA-binding alters the free energy landscape of p53 DBD
and promotes a population shift in the S6-S7 loop
The analyses collected above with the p53DBD(91–289) con-
struct and the available experimentalNMRstudies (39) sug-
gests that the conformational changes in the regions in prox-
imity of the N-terminal tail and the S6-S7 loop are occur-
ring on long timescales that would be difficult to sample ac-
curately by standard MD simulations.
The data collected above allowed uniquely to identify
the S6-S7 loop as potentially influenced long-range by the
DNA binding but they cannot be used for an accurate es-
timate of the populations of the different p53 sub-states in
presence or absence of DNA. Thus, to overcome the intrin-
sic limitations in the conformational sampling of classical
MD and to obtain quantitative information on the popu-
lation of the A-like/D-like states versus C-like/B-like states
and the effect of DNAbinding on the free energy landscape,
we turned to enhanced-sampling techniques. In particular,
we employed PT-metaDwith a set of fourCVs that we chose
based on the distances between key residues of the S6-S7
loop (Asp208 and Phe212) and its surroundings (Glu258,
Glu221, Arg156 and Arg158). Figure 4 reports the 2D free
energy surface (FES) for one pair of collective variables as
an example. The full set of 2D FES plots are reported in
Supplementary Figure S2A.
The PT-metaD simulations clearly show that the 2D FES
of p53DBD is affected byDNA-interaction (Figure 4, Sup-
plementary Figure S2). In particular, we observed a shift
in the populations of the S6-S7 loop toward C-like states
with a concomitant decrease in the populations of A-like
and D-like states from more than 95% (p53DBD(91–289)) to
less than 50–60% (p53DBD–DNA(91–289)). When the domain
is free in solution, A and D are the dominant conforma-
tions, whereas B states are mostly absent and C states con-
stitute a minor population of the ensemble characterized
by a higher free energy with respect to the major state
(G ≈ 2 kcal/mol, Supplementary Figure S2B). DNA
binding decreases the free-energy barriers between the dif-
ferent substates of the S6-S7 loop and at the same time
shifts the populations so that the B/C occluded states are
roughly equally populated compared to theA/D states (Fig-
ure 4, Supplementary Figure S2). The results are also ro-
bust with respect to different force-fields, as illustrated by
the p53DBD–DNA(91–289) and p53DBD(91–289) metaD simula-
tions carried out with the CHARMM22* force field (Fig-
ure 5A) and also p53DBD–DNA(91–289) with recently published
protein–Zn2+ parameters (56) that we here combined with
the CHARMM22/CMAP force field (Supplementary Fig-
ure S2B). There are some differences in the description of
A-like andD-like structures changing the force field, such as
for example with CHARMM22* they are not separated by
high energy barriers (Figure 5A) resulting in populating one
single minimum including either A-like and D-like struc-
tures. Another difference is that with the new Zn2+ param-
eters (56) we did not observe D states and A states are split
in two minima, i.e. A’ and A’′ (Supplementary Figure S2B).
Nevertheless, the differences induced upon DNA binding
are still observable with an increase of the population of the
occluded states of the S6-S7 loop.
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Figure 3. (A) Sub-networks of hydrogen bonds in MD p53 DBD(91–289) simulations. We here show the cluster of hydrogen bonds that involve Thr211 and
Arg213 in the S6-S7 loop, Ser94 and Ser90 of the N-terminal tail, along with Thr170 and Glu171 in the L2 loop. The C atoms of the residues involved in
hydrogen bonds between the S6-S7 loop, the N-terminal tail and other regions are shown as spheres. The C atoms of the interacting residues are connected
by sticks, whose thickness is proportional to the persistence of the interaction. The analysis was carried out by PyInteraph (96). (B and C) Paths of long-
range communication from the L1 to S6-S7 loop. The communication paths are shown as orange (occurrence probability > 0.25) or yellow (occurrence
probability < 0.25) sticks. The terminal nodes of the paths are highlighted as blue and red spheres centred on the C atoms for the S6-S7 and L1 loops,
respectively. The paths calculated from both (B) DNA-unbound simulations and (C) DNA-bound simulations are shown. S6-S7 loop is highlighted in blue.
The paths are listed in Supplementary Table S1.
Figure 4. Interaction with DNA alters the free energy landscape of p53 DBD. The 2D free energy surface (FES) profiles are shown for two out of the four
collective variables employed in PT-metaD simulations. p53DBD(91–289) and p53DBD–DNA(91–289) are shown on the left and right panels, respectively. B and
C-like occluded states (the minima corresponding to lower distances in the plots) are only a minor population in the free state, whereas their population
increases by more than four fold upon DNA binding. The conformation of the loop and the disordered N-terminal tail in each basin of the FES are shown
in red, orange, yellow and green, for A, B, C and D states, respectively. We show only the structure of the p53 DBD for sake of clarity. The average structure
for each p53 state from the unbiased MD simulations is shown as a reference in white cartoons. The other 2D FES profiles are reported in Supplementary
Figure S2B.
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Figure 5. Minor and major states are consistently described by different MD protein force fields and phosphorylation of Ser215 traps the p53 DBD in
the major conformation of S6-S7 loop. The 2D FES profiles are shown for two out of the four collective variables employed in PT-metaD simulations.
p53DBD(91–289) and p53DBD–DNA(91–289) with CHARMM22* force field are shown on the upper left and right panels, respectively. p53DBD(91–289) with
phosphorylation at Ser215 is shown in the bottom panel. A different protein force field (CHARMM22*) provides results consistent with a conformational
shift upon DNA binding in loop S6-S7 towards more occluded states of the loop. Phosphorylation at Ser215 traps the protein in its major state A, also
observed in the X-ray available structures of the protein.
Interestingly, a well-known phosphorylation site at
Ser215, which has been suggested to inhibit transcription
and destabilize the protein (46–48,75), is capable of trapping
p53 in its A/D-like states in the absence of DNA. This de-
creases the propensity for theminor population of the S6-S7
loopwhen the protein in in theDNA-unbound state (Figure
5B), suggesting an extra level of regulation at the conforma-
tional level.
In addition, we calculated C and C NMR chemical
shifts and compared them to previously published values
(38). In particular, we predicted the average chemical shifts
from an ensemble of conformations that included all the
structures in the minima of the 2D FES reported in Fig-
ure 4 for p53DBD–DNA(91–289) using PPM (76). We then also
predicted chemical shifts using uniquely the experimental
X-ray structures that we used as starting structures for our
simulations (Figure 6). Notably, we found a substantially
improved agreement with the experimental data when the
metaD-derived ensemble is used (which includes either the
major and minor states of the S6-S7 loop) with a  2red of
∼2.5 compared to  2red of ∼4.5–8 when the two experi-
mental structures were used. A better agreement with the
experimental data was also locally observed for the S6-S7
loop, where for most of the residues C (Figure 6A) and C
(Figure 6B) chemical shifts featured lower  2 values. The
comparison of our simulated ensemble with the NMR data
support the view that the conformation of the S6-S7 loop is
heterogeneous and that it can exist in multiple substates in
solution.
The S6-S7 loop is close to the disordered N-terminal
region that is known to undergo a slow conformational
exchange in the free protein (39), whereas it is not clear
whether DNA binding modulates this dynamics. The ex-
change between these two experimentally observed states
has previously been related to the disruption of the inter-
actions between Trp91 and Arg174 (39). Indeed, the au-
thors showed that the p53 DBD is characterized by a ma-
jor state (<90% of the ensemble), in which the disordered
tail tightly interacts with the DBD, and a minor population
where these interactions are lost. Our results suggest that
changes in the hydrogen bonds mediated by the residues in
S6-S7 (Figure 3A) could contribute to the process. Accord-
ing to our simulations, the loss of all these interactions not
only causes the opening of the p53-hinge region located N-
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Figure 6. Comparison of calculated and experimental C and C chem-
ical shifts. We predicted C and C chemical shifts using PPM (76) and
compared them to published NMR chemical shifts of p53DBD (38) calcu-
lating a  2 for each atom, accounting also for the errors associated to the
prediction of that specific class of atoms as reported in (76). In the figure,
the results for the residues in the S6-S7 loop and the residue Leu206 in posi-
tion -1 with respect to the loop are reported using as reference the metaD
ensemble and the two different experimental structures used as starting
structure of p53 DBD simulations. We can observe a drop in  2 for most
of the residues when the metaD ensemble is used.
terminal to the DNA-binding domain (Figure 4), but also
promotes the conformational changes in the S6-S7 loop.
Our finding that the DNA alters the free energy landscape
of p53 DBD in the S6-S7 loop suggests that the slow dy-
namics observed byNMR (39) might be regulated viaDNA
binding.
The S6-S7 loop is a recruitment site for biological partners
To correlate the conformational changes observed in the S6-
S7 loop with functional properties, we wondered whether
the different states of the S6-S7 loop could act as hotspots
for protein–protein interactions. We employed the PRISM
method tomodel protein–protein interactions (64).We used
a subset of 40 conformations from our MD simulations of
p53 DBD (95–289), both in the A-like (DNA-bound) and
C-like (DNA-unbound) forms, alongwith the average struc-
tures from each PCA substate (Figure 1B) and available
experimental structures of p53 DBD (PDB entries: 1TSR
chain B (49), 2XWR chain A (50), 2GEQ chain B (77),
1YCS chain A (78)). We selected 54 different proteins with a
known 3D structure that play a role in p53-mediated path-
ways (79) or have been demonstrated to physically inter-
act with the full-length p53 (80) or have been deposited
in the Molecular Interaction database (81) (Supplementary
Table S2). We used these proteins as interaction partners
to be screened for their capability of binding to p53 by
the PRISM method. We evaluated the PRISM results on
the basis of the docking energy scores for the predicted
complexes, using a cutoff value of energy score of −2.39
kcal/mol, as previously suggested (64).
At first, we benchmarked PRISM by evaluating its ca-
pability to predict known protein–protein interfaces in the
complexes of p53DBD and its partners for which experi-
mental structures are already available (38,78,82–84). These
complexes included the apoptosis-stimulating p53 protein
2 (53BP2) (PDB entry 1YCS), RelA-Associated inhibitor
(iASPP) (PDB entry 2VGE), Oncoprotein SV40 Large T-
antigen (PDB entry 2H1L), 53BP1 (PDB entry 1GZH) and
BCL-xL (PDB entry 2MEJ). We used the IS-score (see Ma-
terials and Methods) to compare the predicted interface
with the experimental reference (66). An IS-score of one
would be associated with amodel that perfectly matches the
experimentally known interface. IS-scores in our compar-
isons were generally higher than 0.6 with the exception of
the complex with SV40 Large T-antigen, which was poorly
predicted andwith an IS-score lower than 0.2. In these com-
plexes, the docking scores were in the range of −13 to −5
kcal/mol, confirming the validity of the cutoff proposed by
the PRISM developers (64). Nevertheless, we should notice
that for those proteins for which a template for the interface
is available in the PRISM database (such as 53BP2) the IS-
scores are higher than 0.8, whereas other known complexes
with p53 but currently absent in the PRISM database gen-
erally provide lower IS-scores.
Once validated, we continued to apply PRISM to other
proteins that have been reported to interact with p53.
Our PRISM modelling of complexes with p53DBD or
p53DBD–DNA conformations suggests several interaction
partners for p53 DBD (53BP2, iASPP, Chk1, Casp3, Cdk7,
Crk, Cdk2, Plk1, E2f1, Ku70, Ark1, Supplementary Table
S2, Figure S9), some of which have also been previously
identified (36).
In addition to binding partners that we predicted would
bind to both classes of conformations, we also found pro-
teins that appeared to prefer to interact specifically with
either A-like or C-like conformations. Some of their in-
teraction interfaces on p53 are predicted in the region of
the DBD that comprises the S6-S7, S9-S10 loops and the
-sheet composed of the S4, S9 and S10 -strands (Sup-
plementary Table S2, Figure S9, Figure 7). This obser-
vation suggests that different conformations of the S6-S7
loop affect the spectrum of cofactors for p53 DBD and its
conformation thus plays a role in modulating the recruit-
ment of binding partners. In agreement with this hypoth-
esis, changes in the S6-S7 loop from A-like to C-like con-
formations alter locally the solvent accessible surface, along
with the electrostatic surface potential (Supplementary Fig-
ure S10). The C-like states, which are the ones more popu-
lated in p53DBD–DNA, feature less accessible residues in the
S6-S7 loop (such as Asp208 and Thr211) and in the S4 -
strand (such as Arg158) compared to the A-like structures
(Supplementary Figure S10).
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Figure 7. Complex predicted by PRISM for (A and B) Ku70 and (E and F) Ark-1 p53 DBD. The complex predicted for interaction of Ku70 (PDB entry
1JEY, (97)) and Ark-1 (PDB entry 1MUO (98)) and p53 DBD is depicted as an example of the predicted interfaces reported in Supplementary Table S2.
Moreover the crystallographic structure of the complex between (C and D) Nb139 and p53 DBD is shown for comparison. Structures are shown as a
cartoon. We calculated the residues of the two proteins in each complex that have at least one atom within 5 A˚ of distance from the atoms of the binding
partner and we highlighted their C atoms with coloured spheres. p53 DBD is highlighted in blue, Ku70 in yellow, Ark-1 in cyan and Nb139 in green. The
other interactors identified by PRISM and modulated by different S6-S7 conformations are described in details in the Supplementary Table S2.
Among p53 partners that are likely to interact exclu-
sively with A/D-like states of p53 DBD, we identified pro-
tein kinases, some of which are involved in p53 regulation,
especially Cdk7 and the Aurora-A kinase (Ark1, Figure
7E and F). The results obtained for other kinases are de-
scribed in detail in Supplementary Table S2. Interestingly,
we showed by metaD simulations that phosphorylation oc-
curring at Ser215, which is one of the target site for Ark1
(46,47,85), traps p53 DBD in its major A-like state (Figure
5B). DNA interaction, on the contrary, disfavour the sam-
pling of p53 A/D-like open states (Figure 4) and, accord-
ing to our PRISM analyses, also protects the DBD by the
interaction with Ark1, a kinase that can inhibit p53 tran-
scriptional activity and promote p53 unfolding (46,47).
Interestingly, PRISM also predicts Ku70 as a cofactor
that interacts with p53DBD structures only when the S6-S7
loop is in the A-like conformations with energy docking
scores lower than−2.39 kcal/mol (Supplementary Table S2
and Figure 7A and B). Ku70 is involved in control of apop-
tosis and in transcription-independent functions of p53,
mainly through formation of an inhibitory complex with
Bax, which is a pro-apoptotic factor (86). The Ku70-Bax
complex is cytoprotective and impairs initiation of apop-
tosis (86). In addition, it has been shown that acetylated
p53 in complex with Ku70 can promote the dissociation
of Bax from Ku70 (87,88), contributing to transcription-
independent induction of apoptosis (89). The interaction
between Ku70 and p53 is, however, p53-acetylation inde-
pendent (87). In support of our prediction, mass spectrom-
etry and pull down assays have pointed out that p53 inter-
acts with Ku70 in vitro (87). In our predicted complex, the
p53 DBD interacts with the N-terminal domain of Ku70
while experimental data show that Bax interacts with the
C-terminal region of Ku70 (88), making thus possible the
simultaneous binding of the two proteins with Ku70. Our
predictions suggest that the S6-S7 loop and surrounding
residues recruit the N-terminal domain of Ku70 and this
is possible only when the S6-S7 loop is in A/D-like states,
which are disfavoured by DNA-binding according to our
simulations. We also showed by simulations that the inter-
action withDNA shifts the population of the S6-S7 loop to-
wards occluded conformations that protect from the inter-
action with Ku70, thus down-regulating this transcription-
independent apoptotic mechanism.
Recently a novel nanobody, the monoclonal single-chain
antibody Nb139, was developed to specifically interact with
the wild-type p53 DBD, without altering its structure and
function (90). Although Nb139 does not affect p53 DNA
binding activity, it alters p53 transcriptional activities and
perturbs the transactivation of p53 target genes. The crys-
tallographic structure of the complex of p53DBD andNb139
(Figure 7C and D) shows that the interaction interface of
Nb139 on p53DBD includes many van der Waals interac-
tions and hydrogen bonds in the -sheet region of p53,
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which is flanked by both the S6-S7 loop and the N-terminal
disordered tail (90). The occluded conformations of the S6-
S7 loop promoted by DNA interaction in our simulations
reduce the accessibility of a region that overlaps not only
withKu70 orArk1 binding interfaces but also whereNb139
is known to bind (90).
In particular, using a 5 A˚ distance cutoff in the protein–
protein interfaces of the aforementioned p53-mediated
complexes (p53-Ku70 and p53-Nb139), we found p53
residues such as Ser96, Arg156, Glu204, Tyr205, Asp207,
Asp208, Arg209, Phe212, Thr256, Asp259, Ser260, Ser261
for complexes with ku70 and Tyr103, Pro152, Met160,
Leu206, Asp208, Arg209, Arg158, Asn210, Thr211, Ile254,
Glu258, Asp259, Ser260, Ser261, Asn263, Arg267 for com-
plexes with Nb139.
Altogether our simulations and PRISM analyses suggest
a novel interaction interface for cofactor recruitment on p53
DBD, which could be tested experimentally bymutagenesis.
For example, candidates for experimental mutagenesis are
either residues of the S6-S7 loop (such as Asp207, Asp208,
Arg209 and Thr211), in the S4 -strand (such as Arg158
and Arg156) and in the S9 -strand, such as (Thr256 and
Glu258). All these residues feature changes in their acces-
sibility upon conformational changes of the S6-S7 loop
and are also involved in the interfaces predicted for Ku70,
Nb139 and Ark-1.
In summary, our results overall suggest that the S6-S7
loop of p53DBD ismodulated by the interactionwithDNA
and it is a regulatory site for p53 transcription-independent
functions, possibly involved in recruitment of binding part-
ners and further modulated by post-transcriptional modifi-
cations.
CONCLUSIONS
The available X-ray structures of the p53 DBD show very
similar conformations for both DNA-bound and -unbound
states (91). Nevertheless, high flexibility of p53 DBD has
been suggested as crucial for its biological functions (29).
p53 structural plasticity can also be exploited to design in-
hibitory smallmolecules (92). Conformational changesmay
occur not only at the interface for DNA binding (40,41,43)
but also at distal sites, such as the interface between the p53
DBD core and the disordered N-terminal region (39,74,93)
or the C-terminal domain (44). Until now, many MD stud-
ies of p53 have focused on conformational changes in the
immediate proximity of the DNA binding site (40–43), in-
stead of changes that might potentially occur at distal sites.
p53 is central in cellular signalling and interacts with many
different partners to activate and regulate diverse activities
and biological pathways (29,30). A hub protein such as p53
can either exploit different binding interfaces or can often
use the same binding region to interact with multiple part-
ners (32–34).
Here, we propose that the S6-S7 loop in the p53 DBD
populates different states in solution. In our simulations of
p53DBD(91–289), we were only able to sample these at equilib-
rium using enhanced sampling techniques, suggesting that
they occur on longer timescales than accessible by our un-
biased simulations. Exposed or occluded states of the loop
S6-S7were also observed in recent classicalMD simulations
of a p53 mutant variant with a different force field than the
one here employed (45). The enhanced sampling techniques
that we used makes it possible, in principle, to describe con-
formational changes on the micro-millisecond time scale
(5,25,28), such as the ones experimentally observed for the
regions surrounding the N-terminal disordered tail of p53
DBD (39), where also the S6-S7 loop is located. We found
that DNA binding modulates the populations of different
conformations of the S6-S7 loop. The structural communi-
cation between the two distal sites occurs through the L1
DNA-binding loop and the N-terminal disordered region.
We also showed that post-translational modifications, such
as the phosphorylation of Ser215, could modulate the con-
formational properties of the S6-S7 loop and disfavour the
occluded states for transcription-dependent activity, sug-
gesting a complex network of regulation of p53 function
at the S6-S7 loop. We note that mutations of residues in
the S6-S7 loop are also cancer-related (94,95). Those mu-
tations are known to affect p53 transcriptional regulation
(94,95), suggesting that theDNA-regulated conformational
changes that we observed in the S6-S7 loop have an even
broader functional relevance which might be compromised
by cancer-related mutations.
We found that DNA binding promotes states in which
residues of the S6-S7 loop lose most of the interactions with
the disordered N-terminal region and get involved in inter-
actions with residues in the S4 and S9-strands, as well as in
the L2 loop. In those conformations, certain residues of the
S6-S7 loop and S4 -strand are shielded from the solvent,
altering the accessibility of an interface region that affect the
recruitment of biological cofactors, such asKu70, Ark1 and
Nb139. We predict that they interact more strongly when
p53 DBD is not bound to DNA. We thus speculate that
the population shift of p53DBD towards conformations less
favourable for Ku70 binding could affect the signalling me-
diated by p53. Ku70 interaction with p53 is indeed neces-
sary to release and activate Bax, playing a role in the mul-
tiple steps involved in initiation of the apoptotic pathways
(89). The important role of the p53 DBD in apoptotic regu-
latory functions is also emphasized by the fact that BCL-xL,
in the cytoplasm, interacts on the same surface of the DBD
devoted to DNA-binding (38).
In conclusion, our study points out a new potential reg-
ulatory mechanism of p53 based on distal effects induced
upon DNA binding. DNA binding promotes an interface
conformation that is not compatible with binding to cer-
tain interaction partners, thus protecting p53 from interac-
tion thatmediate transcription-independent functions, such
as transcription-independent apoptosis. As long as p53 is
DNA-bound, the DBD is protected from interactions that
mediate transcription-independent pathways and is able to
carry out its transcription-dependent functions. If experi-
mentally tested and validated, our findings will open up new
avenues for mechanistic exploration towards a better under-
standing of the complex regulatory network mediated by
p53.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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